3.04 USD
↗ 0.04 (1.33%)AT CLOSE (11:59 AM EDT)
Perspective Therapeutics, Inc.
CATXAMEX • USD
3.07
↗ 0.03 (1.12%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
3.07
↗ 0.03 (1.12%)
Market: CLOSED
Perspective Therapeutics, Inc. (CATX) trades at $3.04 per share. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, CATX trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 26, 2026.
Open?$3.00
High?$3.15
Low?$2.94
Prev. Close?$3.00
Volume?9.7M
Avg. Volume?1.9M
VWAP?$3.02
Rel. Volume?5.21x
Bid / Ask
Bid?$2.95 × 1.4K
Ask?$3.20 × 400
Spread?$0.25
Midpoint?$3.08
Valuation & Ratios
Market Cap?346.7M
Shares Out?114.0M
Float?94.7M
Float %?83.0%
P/E Ratio?N/A
P/B Ratio?1.00
EPS?-$0.97
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Employees
166
Market Cap
342.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
SEATTLE, WA 98121
Phone: 206-676-0900
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?29
Momentum?3
Short Sent.?29
Piotroski F-Score?1/9Weak
Altman Z-Score?1.80Distress
Confidence?72%Moderate
Short InterestHigh
Short % of Float?14.40%High
Short Interest?13.6M
Days to Cover?9.0
Free Float94.7M
Avg Daily Volume1.5M
Settlement Date2026-06-15
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?1.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.00CHEAP▾
Peers100
S&P97
P/S?561.00HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.5CHEAP▾
S&P97
EV/Sales?476.28HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-32.0%WEAK▾
S&P6
ROA?-27.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-107447000
Enterprise Value?$294.3M
Fundamentals ratios updated end of day